Literature DB >> 14614369

Use of incubation time to detection in BACTEC 9240 to distinguish coagulase-negative staphylococcal contamination from infection in pediatric blood cultures.

Yishai Haimi-Cohen1, Shideh Shafinoori, Victor Tucci, Lorry G Rubin.   

Abstract

BACKGROUND: Growth of coagulase-negative staphylococci (CoNS) in a blood culture indicates infection or contamination. Differentiation may be difficult in pediatric patients from whom only a single blood culture is commonly obtained.
METHODS: We evaluated the use of the incubation time to detection of growth [time to positive (TTP)] of CoNS in a continuously monitored blood culture system (BACTEC Peds/F bottles in BACTEC 9240) to differentiate infection from contamination. Three groups of febrile pediatric patients with blood cultures growing CoNS were identified: Group 1, children with vascular catheter-associated bloodstream infection; Group 2, previously healthy children with a contaminant; Group 3, chronically ill children with a contaminant.
RESULTS: The median TTP for blood cultures from the 17 infection episodes, 11 h [mean, 13.2 h; 95% confidence interval (CI), 11.4 to 17.7], was significantly shorter than either the 30 episodes in the previously healthy group with contaminant, median 19 h (mean, 22.7 h; 95% CI 19.5 to 26.2; P < 0.0001) or the 12 episodes in the chronically ill group with contaminant, median 24 h (mean, 35.2 h; 95% CI 17.2 to 53.1; P < 0.0001). A TTP of < or =15 h had a positive predictive value of 84% for diagnosis of infection. A TTP of > or =22 h had a positive predictive value of 87% for diagnosis of contaminant.
CONCLUSION: In our experience the TTP was a useful adjunctive test to determine the clinical significance of isolation of CoNS from a blood culture from a pediatric patient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14614369     DOI: 10.1097/01.inf.0000095195.60494.ba

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

Review 1.  Updated review of blood culture contamination.

Authors:  Keri K Hall; Jason A Lyman
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

2.  Time to blood culture positivity as a predictor of clinical outcome of Staphylococcus aureus bloodstream infection.

Authors:  Alexandre R Marra; Michael B Edmond; Betty A Forbes; Richard P Wenzel; Gonzalo M L Bearman
Journal:  J Clin Microbiol       Date:  2006-04       Impact factor: 5.948

3.  Clinical significance of coagulase-negative staphylococci other than S. epidermidis blood stream isolates at a tertiary care hospital.

Authors:  Florian Hitzenbichler; Michaela Simon; Bernd Salzberger; Frank Hanses
Journal:  Infection       Date:  2016-09-22       Impact factor: 3.553

4.  Differentiating culture samples representing coagulase-negative staphylococcal bacteremia from those representing contamination by use of time-to-positivity and quantitative blood culture methods.

Authors:  Christelle Kassis; Gopi Rangaraj; Ying Jiang; Ray Y Hachem; Issam Raad
Journal:  J Clin Microbiol       Date:  2009-08-19       Impact factor: 5.948

5.  True infection or contamination in patients with positive Cutibacterium blood cultures-a retrospective cohort study.

Authors:  Jolin Boman; Bo Nilson; Torgny Sunnerhagen; Magnus Rasmussen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-05-25       Impact factor: 5.103

6.  Development and validation of a risk score for predicting positivity of blood cultures and mortality in patients with bacteremia and fungemia.

Authors:  Felipe Francisco Tuon; João Paulo Telles; Juliette Cieslinski; Marilia Burdini Borghi; Raquel Zanella Bertoldo; Victoria Stadler Tasca Ribeiro
Journal:  Braz J Microbiol       Date:  2021-07-21       Impact factor: 2.214

7.  Retrospective evaluation of the clinical characteristics associated with Corynebacterium species bacteremia.

Authors:  Mitsuru Yanai; Maiko Ogasawasa; Yuta Hayashi; Kiyozumi Suzuki; Hiromichi Takahashi; Atsushi Satomura
Journal:  Braz J Infect Dis       Date:  2018-01-19       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.